NCT06155578View on ClinicalTrials.gov

Safety and Efficacy of Topical Sodium Metabisulfite for the Treatment of Calcinosis in Patients With Systemic Sclerosis

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Systemic SclerosisCalcinosis

Interventions

DRUG

Topical 25% sodium metabisulfite (SM) in pediatric cold cream

Topical 25% sodium metabisulfite (SM) in pediatric cold cream will be applied twice daily on hand calcinosis.

DRUG

Placebo

Pediatric cold cream will be applied twice daily on hand calcinosis.

Trial Locations (1)

8330077

Antonia Valenzuela, Santiago

All Listed Sponsors

collaborator

Liga Panamericana de Asociaciones de Reumatologia (PANLAR)

OTHER

lead

Pontificia Universidad Catolica de Chile

OTHER

NCT06155578 - Safety and Efficacy of Topical Sodium Metabisulfite for the Treatment of Calcinosis in Patients With Systemic Sclerosis | Biotech Hunter | Biotech Hunter